Author:
Zeineddine Maya,Al-Hajje Amal,Ismail Ghida
Publisher
Springer International Publishing
Reference66 articles.
1. Ahmed, S. I., Aziz, K., Gul, A., Samar, S. S., & Bareeqa, S. B. (2019). Risk of multiple sclerosis in Epstein-Barr virus infection. Cureus, 11(9), e5699.
2. Aljumah, M., Alroughani, R., Alsharoqi, I., Bohlega, S. A., Dahdaleh, M., Deleu, D., Esmat, K., Khalifa, A., Sahraian, M. A., Szólics, M., Altahan, A., Yamout, B. I., Rieckmann, P., & Daif, A. (2013). Future of management of multiple sclerosis in the Middle East: A consensus view from specialists in ten countries. Multiple Sclerosis International, 2013, 952321.
3. Alonso, A., & Hernán, M. A. (2008). Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology, 71(2), 129–135.
4. Ascherio, A., & Munger, K. L. (2007). Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Annals of Neurology, 61(6), 504–513.
5. Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A. (2022). Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science, 375(6578), 296–301.